168 related articles for article (PubMed ID: 8507880)
1. Detection by polymerase chain reaction of residual cells with the bcl-2 translocation is associated with increased risk of relapse after autologous bone marrow transplantation for B-cell lymphoma.
Gribben JG; Neuberg D; Freedman AS; Gimmi CD; Pesek KW; Barber M; Saporito L; Woo SD; Coral F; Spector N
Blood; 1993 Jun; 81(12):3449-57. PubMed ID: 8507880
[TBL] [Abstract][Full Text] [Related]
2. Detection of residual lymphoma cells by polymerase chain reaction in peripheral blood is significantly less predictive for relapse than detection in bone marrow.
Gribben JG; Neuberg D; Barber M; Moore J; Pesek KW; Freedman AS; Nadler LM
Blood; 1994 Jun; 83(12):3800-7. PubMed ID: 8204898
[TBL] [Abstract][Full Text] [Related]
3. Polymerase chain reaction detection of cells carrying t(14;18) in bone marrow of patients with follicular and diffuse large B-cell lymphoma: the importance of analysis at diagnosis and significance of long-term follow-up.
Papajík T; Jedlicková K; Kriegová E; Jarosová M; Raida L; Faber E; Hubácek J; Vondráková J; Pikalová Z; Indrák K
Neoplasma; 2001; 48(6):501-5. PubMed ID: 11949845
[TBL] [Abstract][Full Text] [Related]
4. Immunologic purging of marrow assessed by PCR before autologous bone marrow transplantation for B-cell lymphoma.
Gribben JG; Freedman AS; Neuberg D; Roy DC; Blake KW; Woo SD; Grossbard ML; Rabinowe SN; Coral F; Freeman GJ
N Engl J Med; 1991 Nov; 325(22):1525-33. PubMed ID: 1944436
[TBL] [Abstract][Full Text] [Related]
5. Bone marrows of non-Hodgkin's lymphoma patients with a bcl-2 translocation can be purged of polymerase chain reaction-detectable lymphoma cells using monoclonal antibodies and immunomagnetic bead depletion.
Gribben JG; Saporito L; Barber M; Blake KW; Edwards RM; Griffin JD; Freedman AS; Nadler LM
Blood; 1992 Aug; 80(4):1083-9. PubMed ID: 1498325
[TBL] [Abstract][Full Text] [Related]
6. Eradication of polymerase chain reaction detectable immunoglobulin gene rearrangement in non-Hodgkin's lymphoma is associated with decreased relapse after autologous bone marrow transplantation.
Zwicky CS; Maddocks AB; Andersen N; Gribben JG
Blood; 1996 Nov; 88(9):3314-22. PubMed ID: 8896395
[TBL] [Abstract][Full Text] [Related]
7. Failure of immunologic purging in mantle cell lymphoma assessed by polymerase chain reaction detection of minimal residual disease.
Andersen NS; Donovan JW; Borus JS; Poor CM; Neuberg D; Aster JC; Nadler LM; Freedman AS; Gribben JG
Blood; 1997 Nov; 90(10):4212-21. PubMed ID: 9354694
[TBL] [Abstract][Full Text] [Related]
8. Detection of minimal residual disease in patients with childhood common acute lymphoblastic leukemia after autologous bone marrow transplantation with ex vivo purging and systemic IL-2 infusion: unsuccessful prediction of subsequent relapse.
Kiyoi H; Kojima S; Kato K; Matsuyama T; Kodera Y; Ohno R; Naoe T
Bone Marrow Transplant; 1995 Sep; 16(3):437-42. PubMed ID: 8535317
[TBL] [Abstract][Full Text] [Related]
9. All advanced stage non-Hodgkin's lymphomas with a polymerase chain reaction amplifiable breakpoint of bcl-2 have residual cells containing the bcl-2 rearrangement at evaluation and after treatment.
Gribben JG; Freedman As; Woo SD; Blake K; Shu RS; Freeman G; Longtine JA; Pinkus GS; Nadler LM
Blood; 1991 Dec; 78(12):3275-80. PubMed ID: 1742487
[TBL] [Abstract][Full Text] [Related]
10. Autologous bone marrow transplantation in high-risk remission B-lineage acute lymphoblastic leukemia using a cocktail of three monoclonal antibodies (BA-1/CD24, BA-2/CD9, and BA-3/CD10) plus complement and 4-hydroperoxycyclophosphamide for ex vivo bone marrow purging.
Uckun FM; Kersey JH; Haake R; Weisdorf D; Ramsay NK
Blood; 1992 Feb; 79(4):1094-104. PubMed ID: 1531306
[TBL] [Abstract][Full Text] [Related]
11. Detection of tumor cells in purged bone marrow and peripheral-blood mononuclear cells by polymerase chain reaction amplification of bcl-2 translocations.
Negrin RS; Pesando J
J Clin Oncol; 1994 May; 12(5):1021-7. PubMed ID: 8164025
[TBL] [Abstract][Full Text] [Related]
12. High-dose therapy supported with immunomagnetic purged autologous bone marrow in high-grade B cell non-Hodgkin's lymphoma.
Blystad A; Kvalheim G; Torlakovic E; Holte H; Jacobsen E; Beiske K; Vâlerhaugen H; Lenschow E; Kvaloy S
Bone Marrow Transplant; 1999 Oct; 24(8):865-72. PubMed ID: 10516698
[TBL] [Abstract][Full Text] [Related]
13. High-dose therapy and autologous bone marrow transplantation in patients with follicular lymphoma during first remission.
Freedman AS; Gribben JG; Neuberg D; Mauch P; Soiffer RJ; Anderson KC; Pandite L; Robertson MJ; Kroon M; Ritz J; Nadler LM
Blood; 1996 Oct; 88(7):2780-6. PubMed ID: 8839876
[TBL] [Abstract][Full Text] [Related]
14. PCR-positivity in harvested bone marrow predicts relapse after transplantation with autologous purged bone marrow in children in second remission of precursor B-cell acute leukaemia.
Vervoordeldonk SF; Merle PA; Behrendt H; Steenbergen EJ; van den Berg H; van Wering ER; von dem Borne AE; van der Schoot CE; van Leeuwen EF; Slaper-Cortenbach IC
Br J Haematol; 1997 Feb; 96(2):395-402. PubMed ID: 9029032
[TBL] [Abstract][Full Text] [Related]
15. The remission status before and the PCR status after high-dose therapy with peripheral blood stem cell support are prognostic factors for relapse-free survival in patients with follicular non-Hodgkin's lymphoma.
Moos M; Schulz R; Martin S; Benner A; Haas R
Leukemia; 1998 Dec; 12(12):1971-6. PubMed ID: 9844927
[TBL] [Abstract][Full Text] [Related]
16. Long-term follow-up of autologous bone marrow transplantation in patients with relapsed follicular lymphoma.
Freedman AS; Neuberg D; Mauch P; Soiffer RJ; Anderson KC; Fisher DC; Schlossman R; Alyea EP; Takvorian T; Jallow H; Kuhlman C; Ritz J; Nadler LM; Gribben JG
Blood; 1999 Nov; 94(10):3325-33. PubMed ID: 10552941
[TBL] [Abstract][Full Text] [Related]
17. Detection of clonal CD34+19+ progenitors in bone marrow of BCL2-IgH-positive follicular lymphoma patients.
Macintyre EA; Belanger C; Debert C; Canioni D; Turhan AG; Azagury M; Hermine O; Varet B; Flandrin G; Schmitt C
Blood; 1995 Dec; 86(12):4691-8. PubMed ID: 8541563
[TBL] [Abstract][Full Text] [Related]
18. Clinical significance of bcr-abl gene rearrangement detected by polymerase chain reaction after allogeneic bone marrow transplantation in chronic myelogenous leukemia.
Delage R; Soiffer RJ; Dear K; Ritz J
Blood; 1991 Nov; 78(10):2759-67. PubMed ID: 1824268
[TBL] [Abstract][Full Text] [Related]
19. Lymphoma cell burden in progenitor cell grafts measured by competitive polymerase chain reaction: less than one log difference between bone marrow and peripheral blood sources.
Léonard BM; Hétu F; Busque L; Gyger M; Bélanger R; Perreault C; Roy DC
Blood; 1998 Jan; 91(1):331-9. PubMed ID: 9414302
[TBL] [Abstract][Full Text] [Related]
20. Significance of detection of occult non-Hodgkin's lymphoma in histologically uninvolved bone marrow by a culture technique.
Sharp JG; Joshi SS; Armitage JO; Bierman P; Coccia PF; Harrington DS; Kessinger A; Crouse DA; Mann SL; Weisenburger DD
Blood; 1992 Feb; 79(4):1074-80. PubMed ID: 1737092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]